|Articles|May 5, 2017
NNIT Renews Agreement with Novo Nordisk
NNIT announces that it has signed an extension of its infrastructure outsourcing agreement with Novo Nordisk.
Advertisement
NNIT announces that it has signed an extension of its infrastructure outsourcing agreement with Novo Nordisk. The new six-year-agreement replaces and extends an existing infrastructure outsourcing contract between the two parties, covering global services including support and maintenance of Novo Nordisk's corporate IT infrastructure.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
What Patients Want from Remote Trials: New Survey Data Reveals Preferences Around Usability, Trust, and Participation
2
ACT Brief: AI-Enabled End-to-End Trials, New Phase III Data in HIV, and a First-Line Shift in HER2-Positive Breast Cancer
3
FDA Approves GSK’s Exdensur for Severe Asthma Based on SWIFT Phase III Data
4
ACT Brief: Patient Preferences in Remote Trials, Sanofi’s Neurology and Immunology Deals, and AI-Driven Biomarkers in Oncology
5